RAPT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- RAPT Therapeutics initiates prestIgE Phase 2b clinical trial of Ozureprubart (RPT904) in patients with food allergiesOct 27, 2025
- RAPT Therapeutics to report topline data from Phase 2 clinical trial of RPT904 in chronic spontaneous urticariaOct 20, 2025
- RAPT Therapeutics and Shanghai Jeyou Pharmaceutical announce positive topline data from Phase 2 trial of RPT904 (JYB1904) in chronic spontaneous urticariaOct 20, 2025
- RAPT Therapeutics announces FDA clearance of IND application to proceed to Phase 2b trial of RPT904 in food allergySep 29, 2025